Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06212882
NA

Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material

Sponsor: Wuxi People's Hospital

View on ClinicalTrials.gov

Summary

The investigators aimed to compare the image quality and diagnostic performance of DECTPA using lower concentration iodine contrast materials and using normal concentration iodine contrast materials in the evaluation of suspected pulmonary embolism.

Official title: Dual Energy CT Angiography in Suspected Pulmonary Embolism: Influence of Concentration of Contrast Materials on Image Quality and Diagnostic Performance

Key Details

Gender

All

Age Range

18 Years - 97 Years

Study Type

INTERVENTIONAL

Enrollment

2216

Start Date

2023-09-28

Completion Date

2026-06-30

Last Updated

2026-10-29

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

DE-CTPA with 30 mL iomeprol 300 mg I/mL

Dual-energy CTPA was performed after intravenous administration of 30 mL of iomeprol (300 mg I/mL) at an injection rate of 4.0 mL/s, followed by a 30-mL saline chaser.

DIAGNOSTIC_TEST

DE-CTPA with 50 mL iomeprol 300 mg I/mL

Dual-energy CTPA was performed after intravenous administration of 50 mL of iomeprol (300 mg I/mL) at an injection rate of 4.0 mL/s, followed by a 30-mL saline chaser.

DIAGNOSTIC_TEST

DE-CTPA with 50 mL Ioversol 350 mg I/mL

Dual-energy CTPA was performed after intravenous administration of 50 mL of Ioversol (350 mg I/mL) at an injection rate of 4.0 mL/s, followed by a 30-mL saline chaser.

Locations (1)

Wuxi People's Hospital

Wuxi, Jiangsu, China